Integra LifeSciences (IART) Revenue & Revenue Breakdown
Integra LifeSciences Revenue Highlights
Latest Revenue (Y)
$1.54B
Latest Revenue (Q)
$418.18M
Main Segment (Y)
Codman Specialty Surgical
Main Geography (Y)
UNITED STATES
Integra LifeSciences Revenue by Period
Integra LifeSciences Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $1.54B | -1.03% |
| 2022-12-31 | $1.56B | 0.99% |
| 2021-12-31 | $1.54B | 12.43% |
| 2020-12-31 | $1.37B | -9.60% |
| 2019-12-31 | $1.52B | 3.06% |
| 2018-12-31 | $1.47B | 23.92% |
| 2017-12-31 | $1.19B | 19.77% |
| 2016-12-31 | $992.08M | 12.39% |
| 2015-12-31 | $882.73M | -4.91% |
| 2014-12-31 | $928.30M | 11.01% |
| 2013-12-31 | $836.21M | 0.64% |
| 2012-12-31 | $830.87M | 6.51% |
| 2011-12-31 | $780.08M | 6.56% |
| 2010-12-31 | $732.07M | 7.26% |
| 2009-12-31 | $682.49M | 4.26% |
| 2008-12-31 | $654.60M | 18.92% |
| 2007-12-31 | $550.46M | 31.28% |
| 2006-12-31 | $419.30M | 50.86% |
| 2005-12-31 | $277.94M | 20.93% |
| 2004-12-31 | $229.82M | 23.83% |
| 2003-12-31 | $185.60M | 64.79% |
| 2002-12-31 | $112.63M | 20.53% |
| 2001-12-31 | $93.44M | 43.79% |
| 2000-12-31 | $64.99M | 52.91% |
| 1999-12-31 | $42.50M | 142.86% |
| 1998-12-31 | $17.50M | 19.05% |
| 1997-12-31 | $14.70M | 12.21% |
| 1996-12-31 | $13.10M | 28.43% |
| 1995-12-31 | $10.20M | - |
Integra LifeSciences generated $1.54B in revenue during NA 2023, up -1.03% compared to the previous quarter, and up 104.70% compared to the same period a year ago.
Integra LifeSciences Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $418.18M | 13.37% |
| 2024-03-31 | $368.87M | -7.09% |
| 2023-12-31 | $397.04M | 3.82% |
| 2023-09-30 | $382.42M | 0.30% |
| 2023-06-30 | $381.27M | 0.11% |
| 2023-03-31 | $380.85M | -4.32% |
| 2022-12-31 | $398.02M | 3.33% |
| 2022-09-30 | $385.19M | -3.17% |
| 2022-06-30 | $397.81M | 5.62% |
| 2022-03-31 | $376.64M | -7.12% |
| 2021-12-31 | $405.52M | 4.82% |
| 2021-09-30 | $386.86M | -0.80% |
| 2021-06-30 | $389.99M | 8.31% |
| 2021-03-31 | $360.07M | -7.35% |
| 2020-12-31 | $388.65M | 4.97% |
| 2020-09-30 | $370.23M | 43.13% |
| 2020-06-30 | $258.67M | -27.00% |
| 2020-03-31 | $354.32M | -10.33% |
| 2019-12-31 | $395.13M | 4.23% |
| 2019-09-30 | $379.10M | -1.19% |
| 2019-06-30 | $383.64M | 6.66% |
| 2019-03-31 | $359.69M | -6.16% |
| 2018-12-31 | $383.31M | 4.77% |
| 2018-09-30 | $365.85M | -0.09% |
| 2018-06-30 | $366.19M | 2.55% |
| 2018-03-31 | $357.08M | -3.13% |
| 2017-12-31 | $368.60M | 32.19% |
| 2017-09-30 | $278.83M | -1.18% |
| 2017-06-30 | $282.16M | 9.10% |
| 2017-03-31 | $258.64M | 1.16% |
| 2016-12-31 | $255.66M | 2.13% |
| 2016-09-30 | $250.33M | 0.41% |
| 2016-06-30 | $249.31M | 5.30% |
| 2016-03-31 | $236.77M | -1.82% |
| 2015-12-31 | $241.16M | 6.53% |
| 2015-09-30 | $226.37M | -7.26% |
| 2015-06-30 | $244.08M | 4.46% |
| 2015-03-31 | $233.66M | -7.34% |
| 2014-12-31 | $252.18M | 9.78% |
| 2014-09-30 | $229.72M | -0.71% |
| 2014-06-30 | $231.35M | 7.58% |
| 2014-03-31 | $215.06M | -2.59% |
| 2013-12-31 | $220.77M | 3.53% |
| 2013-09-30 | $213.25M | 3.75% |
| 2013-06-30 | $205.55M | 4.52% |
| 2013-03-31 | $196.65M | -8.29% |
| 2012-12-31 | $214.43M | 2.07% |
| 2012-09-30 | $210.08M | -0.04% |
| 2012-06-30 | $210.17M | 7.13% |
| 2012-03-31 | $196.19M | -3.61% |
| 2011-12-31 | $203.52M | 0.66% |
| 2011-09-30 | $202.19M | 4.58% |
| 2011-06-30 | $193.33M | 6.79% |
| 2011-03-31 | $181.04M | -6.74% |
| 2010-12-31 | $194.13M | 4.01% |
| 2010-09-30 | $186.64M | 4.51% |
| 2010-06-30 | $178.59M | 3.41% |
| 2010-03-31 | $172.70M | -5.90% |
| 2009-12-31 | $183.53M | 6.52% |
| 2009-09-30 | $172.29M | 3.96% |
| 2009-06-30 | $165.72M | 2.97% |
| 2009-03-31 | $160.95M | -7.70% |
| 2008-12-31 | $174.37M | 4.40% |
| 2008-09-30 | $167.03M | 6.25% |
| 2008-06-30 | $157.20M | 0.76% |
| 2008-03-31 | $156.01M | -1.04% |
| 2007-12-31 | $157.65M | - |
Integra LifeSciences generated $418.18M in revenue during Q2 2024, up 13.37% compared to the previous quarter, and up 109.80% compared to the same period a year ago.
Integra LifeSciences Revenue Breakdown
Integra LifeSciences Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 22 | Dec 21 | Dec 20 | Dec 19 | Dec 18 |
|---|---|---|---|---|---|
| Tissue Technologies | $538.10M | $517.22M | - | - | - |
| Codman Specialty Surgical | $1.02B | $1.03B | $894.83M | $996.21M | $963.93M |
| Orthopedics and Tissue Technologies | - | - | $477.04M | $521.35M | $508.51M |
Integra LifeSciences's latest annual revenue breakdown by segment (product or service), as of Dec 22: Codman Specialty Surgical (65.45%), and Tissue Technologies (34.55%).
Quarterly Revenue by Product
| Product/Service | Jun 24 | Mar 24 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tissue Technologies | $116.41M | $112.44M | $114.22M | $110.24M | $132.71M | $133.43M | $135.40M | $139.95M | $129.33M | $134.87M | $130.36M | $133.16M | $118.83M | - | - | - | - | - | - | - |
| Codman Specialty Surgical | $301.76M | $256.43M | $268.20M | $271.03M | $248.14M | $264.60M | $249.80M | $257.86M | $247.31M | $270.66M | $256.50M | $256.84M | $241.24M | $254.29M | $239.32M | $169.78M | $231.44M | $259.40M | $252.98M | $249.26M |
| Orthopedics and Tissue Technologies | - | - | - | - | - | - | - | - | - | - | - | - | - | $134.36M | $130.91M | $88.89M | $122.88M | $135.73M | $126.11M | $134.39M |
Integra LifeSciences's latest quarterly revenue breakdown by segment (product or service), as of Jun 24: Codman Specialty Surgical (72.16%), and Tissue Technologies (27.84%).
Integra LifeSciences Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 22 | Dec 21 | Dec 20 | Dec 19 | Dec 18 |
|---|---|---|---|---|---|
| UNITED STATES | $1.13B | $1.09B | $971.98M | $1.08B | $1.05B |
| Europe | $170.90M | $191.33M | $172.69M | $197.47M | $201.35M |
| Asia Pacific | $176.48M | $182.03M | $157.17M | $157.39M | $144.25M |
| Rest Of World | $83.48M | $79.56M | $70.03M | $85.32M | $80.95M |
Integra LifeSciences's latest annual revenue breakdown by geography, as of Dec 22: UNITED STATES (72.34%), Asia Pacific (11.33%), Europe (10.97%), and Rest Of World (5.36%).
Quarterly Revenue by Country
| Country | Jun 24 | Mar 24 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rest Of World | $21.31M | $21.50M | $22.28M | $19.33M | $18.31M | $19.31M | $22.10M | $20.24M | $21.83M | $21.72M | $19.61M | $19.06M | $19.16M | $19.84M | $17.29M | $11.29M | $21.62M | $22.85M | $21.49M | $22.35M |
| Asia Pacific | $45.95M | $49.55M | $48.78M | $47.71M | $50.47M | $42.62M | $42.77M | $43.37M | $47.72M | $45.42M | $45.02M | $44.31M | $47.30M | $43.24M | $40.47M | $33.50M | $39.96M | $42.58M | $42.08M | $37.03M |
| UNITED STATES | $310.23M | $256.23M | $269.84M | $276.78M | $271.00M | $294.10M | $282.02M | $287.35M | $263.35M | $287.77M | $275.77M | $278.19M | $247.79M | $276.80M | $266.48M | $181.85M | $246.85M | $280.98M | $266.28M | $273.39M |
| Europe | $40.69M | $41.60M | $41.52M | $37.45M | $41.06M | $42.00M | $38.30M | $46.86M | $43.74M | $50.61M | $46.46M | $48.44M | $45.82M | $48.77M | $45.99M | $32.03M | $45.90M | $48.72M | $49.24M | $50.87M |
Integra LifeSciences's latest quarterly revenue breakdown by geography, as of Jun 24: UNITED STATES (74.19%), Asia Pacific (10.99%), Europe (9.73%), and Rest Of World (5.10%).
IART Revenue FAQ
What is Integra LifeSciences’s yearly revenue?
Integra LifeSciences's yearly revenue for 2023 was $1.54B, representing a decrease of -1.03% compared to 2022. The company's yearly revenue for 2022 was $1.56B, representing an increase of 0.99% compared to 2021. IART's yearly revenue for 2021 was $1.54B, representing an increase of 12.43% compared to 2020.
What is Integra LifeSciences’s quarterly revenue?
Integra LifeSciences's quarterly revenue for Q2 2024 was $418.18M, a 13.37% increase from the previous quarter (Q1 2024), and a 9.68% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $368.87M, a -7.09% decrease from the previous quarter (Q4 2023), and a -3.14% decrease year-over-year (Q1 2023). IART's quarterly revenue for Q4 2023 was $397.04M, a 3.82% increase from the previous quarter (Q3 2023), and a -0.25% decrease year-over-year (Q4 2022).
What is Integra LifeSciences’s revenue growth rate?
Integra LifeSciences's revenue growth rate for the last 3 years (2021-2023) was -0.06%, and for the last 5 years (2019-2023) was 1.58%.
What are Integra LifeSciences’s revenue streams?
Integra LifeSciences's revenue streams in c 22 are Tissue Technologies, and Codman Specialty Surgical. Tissue Technologies generated $538.1M in revenue, accounting 34.55% of the company's total revenue, up 4.04% year-over-year. Codman Specialty Surgical generated $1.02B in revenue, accounting 65.45% of the company's total revenue, down -0.55% year-over-year.
What is Integra LifeSciences’s main source of revenue?
For the fiscal year ending Dec 22, the largest source of revenue of Integra LifeSciences was Codman Specialty Surgical. This segment made a revenue of $1.02B, representing 65.45% of the company's total revenue.